Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Interaction of family history, physical activity and environmental factors in the risk for the development of prostate cancer

Principal Investigator
Name
Omar Abdel-Rahman
Degrees
MD
Institution
Avicenna Oncology Center
Position Title
Consultant and lecturer
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-398
Initial CDAS Request Approval
Sep 25, 2018
Title
Interaction of family history, physical activity and environmental factors in the risk for the development of prostate cancer
Summary
A number of factors have been linked to the risk of developing prostate cancer, including positive family history, lack of exercise, higher body mass index and metabolic syndrome. The current project aims to analyse the extent of interaction of these factors in the formulation of prostate cancer risk. Moreover, it aims to determine if risk factors for low grade prostate cancer are different from those predisposing to high grade prostate cancer. The current project might lead to a deeper understanding of the development of different subtypes of prostate cancer. Thus, it might impact our screening/ prevention strategies for this disease in the future.
Aims

1. To clarify the extent of interaction of family history with other physical environmental risk factors in the development of prostate cancer.
2. To clarify if risk factors for lower grade prostate cancer are different from or similar to risk factors for high grade prostate cancer.
3. To clarify if prostate cancer screening strategies can be more personalized according to baseline risk factors of different patient subgroups.

Collaborators

No collaborators

Related Publications